What is the optimal maintenance treatment for perianal Crohn's disease?
Schwartz
David A
DA
Inflammatory Bowel Disease Center, Vanderbilt University Medical Center, Tennessee, USA.
D000893:Anti-Inflammatory Agents / Q000008:administration & dosage*; D001004:Anus Diseases / Q000175:diagnosis / Q000188:drug therapy* / Q000209:etiology / Q000517:prevention & control; D003131:Combined Modality Therapy; D003424:Crohn Disease / Q000150:complications / Q000188:drug therapy* / Q000517:prevention & control; D004359:Drug Therapy, Combination; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage*; D007412:Intestinal Fistula / Q000175:diagnosis / Q000188:drug therapy* / Q000209:etiology / Q000517:prevention & control; D008279:Magnetic Resonance Imaging; D012074:Remission Induction; D013997:Time Factors; D016896:Treatment Outcome
D000893:Anti-Inflammatory Agents; D007166:Immunosuppressive Agents